Science Current Events | Science News | Brightsurf.com
 

Cancer-causing Agents Current Events | Cancer-causing Agents News | 8
Page 8 of 125 | 3122 Results
Previous0304050607080910111213   Next   
Sort By: Page Views | Date
Green tea and COX-2 inhibitors combine to slow growth of prostate cancer
Drinking a nice warm cup of green tea has long been touted for its healthful benefits, both real and anecdotal. But now researchers have found that a component of green tea, combined with low doses of a COX-2 inhibitor, could slow the spread of human prostate cancer.   view more (2007-03-01)

Safety of antithrombotic treatment in acute coronary syndromes
The management of acute coronary syndromes (with or without ST segment elevation) requires the use of anticoagulants, antiplatelet agents (aspirin, clopidogrel and/or glycoprotein (GP) IIb/IIIa inhibitors), beta-blockers, thrombolytics in some cases, and revascularization / reperfusion.   view more (2008-09-03)

A fundamentally new approach to improving cancer chemotherapy
A new strategy for getting anti-cancer drugs to kill cancer cells, without causing serious harm to normal cells in the body, is reported in the current [June] issue of ACS Chemical Biology, a monthly peer-reviewed journal of the American Chemical Society.   view more (2006-06-06)

H. Pylori bacteria may help prevent some esophageal cancers
Some bacteria may help protect against the development of a type of esophageal cancer, known as adenocarcinoma, according to a new review of the medical literature. These bacteria, which are called Helicobacter pylori, live in the stomachs of humans.    view more (2008-10-06)

OHSU Cancer Institute researchers pinpoint how smoking causes cancer
Oregon Health & Science University Cancer Institute researchers have pinpointed the protein that can lead to genetic changes that cause lung cancer.   view more (2008-05-14)

Using coxibs and NSAIDs to treat osteoarthritis
A panel of arthritis research experts has recommended that coxibs and nonsteroidal anti-inflammatory drugs (NSAIDs) must remain a significant part of the tool kit used in treating osteoarthritis (OA).   view more (2007-08-13)

Study broadens understanding of enzymes linked to tumor promoting molecule
Virginia Commonwealth University Massey Cancer Center researchers have found that two enzymes that catalyze the same reaction and produce the same product have opposite effects on cell growth and death.   view more (2005-11-07)

Bacteria have their own immune system protecting against outside DNA
Bacteria like Salmonella have a complicated immune system that helps them recognize and isolate foreign DNA trying to invade their cell membrane.   view more (2006-06-09)

The good and bad side of anti-cancer compounds
Compounds known as "HDAC inhibitors" exhibit cancer-killing activities in cultured cells. While they are currently being tested as anti-cancer agents in clinical trials, just how they execute their effects is unclear.   view more (2008-04-11)

Targeting leukemic stem cells by Bcl-2 inhibition
Researchers at The University of Texas M. D. Anderson Cancer Center have found, in laboratory studies, that the experimental drug ABT-737 which has shown promise in some cancers, can destroy acute myeloid leukemia (AML) blast, progenitor and even stem cells that are often resistant to standard... view more (2006-11-20)

'Killer' cells used to combat rare cancer
Scientists from the University of Edinburgh are using immune cells harvested from blood donors to help fight an unusual cancer which can affect transplant patients. And their findings, published recently in The Lancet show that the therapy has proved effective in a number of cases. The treatment... view more (2002-09-10)

Vitamin D inhibits progression of some prostate cancers
Vitamin D can inhibit the spread of prostate cancer cells by limiting the activity of two specific enzymes, University of Rochester Medical Center scientists report.   view more (2006-02-09)

Gold nanoparticles show potential for noninvasive cancer treatment
Researchers from the University of California, San Francisco and Georgia Institute of Technology have found a new way to kill cancer cells. Building on their previous work that used gold nanoparticles to detect cancer, they now are heating the particles and using them as agents to destroy malignant... view more (2005-10-10)

Resistance to chemotherapy in lung cancer, optimizing flu vaccination strategies
Lung cancer is the most common cause of cancer-related death worldwide, in part because these tumors often are or become resistant to chemotherapy.   view more (2006-10-03)

Bisphenol A linked to chemotherapy resistance
Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists.   view more (2008-10-09)

p53, tumor suppression and aging
In the January 1 issue of Genes & Development, Dr. Mary Ellen Perry and colleagues validate the p53 inhibitor, Mdm2, as a promising target for cancer therapies.   view more (2006-01-03)

Cervical cancer - a single vaccine could benefit most women
The risk of developing cervical cancer by women infected with the Human Papillomavirus (HPV) is essentially the same no matter which type of virus is involved, provided it belongs to the group of 15 or so that are currently identified as high risk, a scientist said today.   view more (2003-09-20)

Study: Harmless virus kills some cancers
Six days is all it takes for a common, non-disease-causing virus to kill cervical, breast, prostate and squamous cell cancer cells in laboratory cultures, according to Penn State College of Medicine researchers.   view more (2005-06-22)

Nature's weapon against nerve agents
An enzyme found naturally in the blood could help protect soldiers against the effects of the deadly nerve agent sarin, reports Cath O'Driscoll in the Society of Chemical Industry's magazine Chemistry & Industry, the magazine of the SCI.   view more (2007-07-30)

How to treat gastroesophageal adenocarcinom patients?
Gastroesophageal adenocarcinomas have a poor prognosis. However, numerous randomized clinical trials (RCT) have evaluated, and continue to evaluate, the survival benefit of various treatment regimens.   view more (2008-09-18)

New Guidelines for Treating Rheumatoid Arthritis
Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alabama at Birmingham... view more (2008-07-23)

Researchers break chain of biochemical events that brain cancer cells use to evade therapy
In their quest to find and exploit vulnerabilities in the natural armor that protects malignant brain tumors from destruction, researchers have found a way to decrease the cells resistance to therapies that are designed to trigger cell death.   view more (2006-02-06)

Is Bcl-2 protein a major obstacle in treating colorectal carcinoma?
Apoptosis resistance has been shown to contribute to the development of different cancer entities, such as colorectal carcinoma (CRC).   view more (2008-09-24)

MicroRNAs make for safer cancer treatments
Viruses -- long regarded solely as disease agents -- now are being used in therapies for cancer. Concerns over the safety of these so-called oncolytic viruses stem from their potential to damage healthy tissues.   view more (2008-10-27)

Little lifesavers — Nanoparticles improve delivery of medicines and diagnostics
Tiny, biodegradable particles filled with medicine may also contain answers to some of the biggest human health problems, including cancer and tuberculosis. The secret is the size of the package.   view more (2007-04-11)
Page 8 of 125 | 3122 Results
Previous0304050607080910111213   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com